India can step up as Living Laboratory for the world, says Union Minister Chandra Shekhar
Speaking at the inaugural edition of ETHealthworld FutureMed X - The Smart Patient Care Summit, the Minister of State for Communications & Ministry of Rural Development, said the country has the potential to serve as a "living laboratory" for the world. and building on the existing evidence India can develop its own high-quality scalable solutions and drive healthcare digital transformation.'
With collaboration between entrepreneurs and the government, we can make this process successful and ensure that our citizens receive healthcare services that meet global quality standards, the minister added.
Delivering the Chief Guest address, Dr Chandra Sekhar noted, with record investment in medical education, the country is nearing to achieve the World Health Organisation (WHO) optimal number of doctors and integration of telemedicine has further boosted access to services.
Speaking further, the Union Minister stressed that entrepreneurs in the country can explore innovative business models to address healthcare challenges, such as drone-based delivery of essential medicines and mobile vans equipped with trained MBBS doctors and physicians.
Advocating for self-reliance, Dr Chandra Sekhar said that India needs to develop its own system and needs to focus on investing in primary and preventive care.
By leveraging digital infrastructure and implementing price controls, along with effective workforce planning, the country can overcome existing healthcare challenges, he added.
The inaugural edition FutureMed X - The Smart Patient Care Summit designed to discuss and understand the dynamics of
AI-driven diagnostics
,
IoT-enabled healthcare
, telemedicine, and data-driven decision-making—paving the way for a more intelligent, connected, and patient-first healthcare ecosystem.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
8 hours ago
- Indian Express
Govt not to allow sale of biostimulants without scientific approval: Shivraj Singh Chouhan
Two days after he asked chief ministers of states to immediately stop forced sale of nano-fertilisers and biostimulants to farmers, Union Agriculture Minister Shivraj Singh Chouhan Tuesday said the government will not allow the sale of biostimulants without scientific nod. He directed the officials of his ministry to put in place 'clear rules and SOPs (standard operating procedures)' for the sale of biostimulants. Chairing a meeting, Chouhan said that farmers raised numerous complaints about the sale of fake fertilisers, seeds, biostimulants, and nano urea during his visits to villages as part of recently concluded 15-day 'Viksit Krishi Sankalp Abhiyan', where he held direct interactions with them. Chouhan questioned why biostimulants, despite repeated renewals and years of sales, were still in the market even after several complaints stated that they were ineffective. 'Now, only those biostimulants that meet all the criteria and are proven beneficial to farmers will be approved. Approvals will now be based solely on scientific validation, and the responsibility for this will rest entirely with the concerned officials,' he said, according to an official statement. Many companies started selling biostimulants without any rules, but the government will not let this happen at any cost, he said, adding that the government will take action against suspicious manufacturers of biostimulants. 'It is necessary to review biostimulants thoroughly to see how much benefit the farmers are getting from it; if not, then permission to sell it cannot be given,' Chouhan said. He also emphasised the need for the Indian Council of Agricultural Research (ICAR) to evaluate biostimulants. Chouhan instructed the officials to put in place clear rules and SOPs, and said that irregularities will no longer be tolerated. Biostimulants are substances or microorganisms (such as beneficial bacteria, fungi, or plant extracts) that, when applied to seeds, plants, or soil, stimulate natural plant processes. The minister pointed out that for several years, around 30,000 biostimulant products were being sold unchecked, and even in the last four years, around 8,000 products remained in circulation. 'After I enforced stricter checks, the number has now come down to around 650,' he said. It is learnt that the meeting was called impromptu and no notice was given to officials. The meeting was attended by the officials of the Ministry of Agriculture and Farmers Welfare and the ICAR. The biostimulants market in India was valued at approximately USD 355–362 million in 2024 and is projected to reach between USD 1.13 billion and USD 1.2 billion by 2032. On July 13, Chouhan had asked the state governments to immediately stop the 'forced tagging' of nano-fertilisers or biostimulants along with conventional fertilisers such as urea and diammonium phosphate (DAP). In a letter to chief ministers, Chouhan highlighted complaints that retailers are not selling subsidised conventional fertilisers such as urea, DAP, etc. to farmers unless they purchase nano-fertilisers or biostimulants.
Time of India
9 hours ago
- Time of India
PIB busts myth: No health warnings issued on samosas and jalebis
India's Ministry of Health directed central institutions to display 'oil and sugar boards' to raise awareness about hidden fats and sugars in common foods. This initiative aims to promote healthier lifestyles and combat obesity and non-communicable diseases. Recently, India's beloved street snacks came under scrutiny, when the Ministry of Health directed all central government institutions to install prominent "oil and sugar boards", that warns citizens about the hidden fat and sugar content in everyday foods like samosas, jalebis, vada pavs. In a post on X, the Indian Council of Medical Research (ICMR) confirmed receiving the notice, lauding the Centre for the initiative. The research institute also shared its own 'Sugar Board' that will be displayed in its offices. All of this led to misleading news circulations where sugar and trans fats were considered the new tobacco. The intent of the move was to help inform people about what they eat and how they should eat. As soon as the news spread, the Press Information Bureau (PIB), fact checking wing on Tuesday said that the Union health ministry did not advise vendors to carry warning labels on popular Indian snacks and desserts. "The advisory of the Union Health Ministry does not carry any warning labels on food products sold by vendors, and has not been selective towards Indian snacks. Some media reports claim that the @MoHFW_INDIA has issued a health warning on food products such as samosas, jalebis, and laddoo," the PIB posted on X. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 요즘 SNS에서 핫한 그 반지, 기부로 받을 수 있다고? 굿네이버스 더 알아보기 Undo The PIB called the government's issue a general advisory a "behavioral nudge to make people aware of hidden fats and excess sugar in all food products, and not specially to any particular food products." The clarification followed after the Ministry of Health & Family Welfare rolled out a public health initiative aimed at promoting healthier lifestyles and combating the growing burden of obesity and non-communicable diseases (NCDs) like diabetes and heart disease. As per reports, the details in a letter issued by Union Healthy Secretary Punya Salila Srivastava said, "We are proposing the display of Sugar and Oil Boards as an initiative to promote healthier dietary habits in various settings. These boards serve as visual behavioural nudges in schools, offices, public institutions, etc., displaying key information about hidden fats and sugars in everyday foods." "In the same spirit, I request you to issue directions kindly to Departments/Offices/autonomous bodies and other public institutions/organisations under your Ministry to install Oil and Sugar Board displays (Digital/ Static posters etc) in common areas (cafeterias, lobbies, meeting rooms and other public spaces) to raise awareness on harmful consumption," the letter read. All Images Courtesy: istock
Time of India
10 hours ago
- Time of India
AI, Modern Tech & the evolving dynamics of Patient Care in India
New Delhi: As healthcare professionals in India increasingly adopt digital tools in clinical practice , advancements such as genomics, AI, and data analytics are transforming patient care—enabling personalized treatments and accelerating timely, effective interventions. While adoption is steadily increasing, it faces significant challenges—including inadequate infrastructure, rising costs, and unresolved data privacy concerns. Delving into this space the inaugural edition of ETHealthworld FutureMed X - The Smart Patient Care Summit convened a panel discussion on Reengineering Patient Care- A Changemakers Perspective. The experts who shared their insights at the session included Prof Anurag Agrawal, Head-Koita Center for Digital Health & Dean - BioSciences and Health Research, Ashoka University, Dr. Raj Shankar Ghosh, Senior Advisor, Environmental Health, Public Health Foundation of India (PHFI), Dr Chandrakant Lahariya Founder -Director, Foundation of People Centric Health System; Leena Menghaney, Lawyer/Consultant, Public Health, Pharmaceuticals & Access; and the discussion was moderated by Vikas Dandekar Editor ETHealthworld, The Economic Times. AI diagnostics drive and the mid way challenges Radiology services in India stands as a frontrunner in AI adoption, where its integration is helping them to cut down time lines of analysing millions of scans, However Prof Agrawal, noted, 'while radiologist have increasingly adopted AI these tools are not yet advanced enough to be fully relied upon for clinical decision-making and the coming age of medical professionals is facing entering a field where technological integration presents both promise and pressure.' Citing examples like Continuous Glucose Monitoring (CGM)--a technology used to track glucose levels in real-time round the clock—Lehariya stressed that such innovations have shown their potential but their adoption is yet to scale up in India and the growing integration of artificial intelligence (AI) in healthcare should prioritise expanding access, reaching underserved communities, and improving outcomes on the ground.' 'We will keep evolving and innovating new things but from the very beginning we should focus on taking those innovations to a broader section of society and unless that is achieved it will be partial success,' Dr Lehariya stressed. 'The advent of AI is steadily making its mark in healthcare. To develop a comprehensive, integrated solution for diverse health challenges, stakeholders must unite their efforts toward the concept of One Health—linking environmental, animal, and human health, Dr Ghosh, said 'Empowering communities to build trust is essential, so AI becomes part of daily life and effectively addresses a range of healthcare issues,' he added. Policy Efforts On the policy front, Menghaney emphasized the introduction of HMIS (Health Management Information System) reflects some potential; the absence of ethical frameworks hinders accountable use of digital tools, and introducing strong data protection provisions is essential to unlock the benefits of digitization in public health decision-making. To counter misinformation Prof Aggarwal suggested that, 'there should be constant level of high-surveillance all the time, creation of trusted voices with continuous release of information to counter various misleading information and myths While India's healthcare system has long been oriented toward treating infectious and acute diseases, the rising prevalence of non-communicable diseases (NCDs) demands a shift in approach. Clinicians and healthcare providers must rethink existing models and adopt innovative strategies to meet this emerging challenge. Dr Lehariya added that, while India's healthcare system has long been oriented toward treating infectious and acute diseases, the rising prevalence of non-communicable diseases (NCDs) demands a shift in approach.
